About D2L Pharma Research Solutions
D2L Pharma Research Solutions is a Healthcare company based in Bengaluru (India) founded in 2007 by Shekhar Gupta and Deepak Harikrishnan. It provides consulting services for Key Opinion Leader development in pharmaceuticals. It operates on a B2B model. The company has 47 employees. Its chief executive, as recorded, is Deepak Harikrishnan. Its Indian entity D2l Pharma Research Solutions Private Limited reported revenue of ₹8.09 Cr. Its focus areas include Pharmaceuticals, Research Consulting and KOL Development.
Company details
D2L Pharma Research Solutions, established in 2007, excels in providing healthcare solutions, producing pharmaceutical products, research consulting, and kol development. Provides consulting services for Key Opinion Leader development in pharmaceuticals. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Bengaluru, India
- Employees 47
- Founders Shekhar Gupta, Deepak Harikrishnan
- SectorsHealthcare
- Email••••••••
- Website d2lpharma.com
- Social LinkedIn X Facebook
- Legal Name D2l Pharma Research Solutions Private Limited
- Date of Incorporation 06 Jul, 2007
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹8.09 Cr
FY 2025 · +19% YoY
- Net Loss-₹68.6 Lakh
FY 2025 · -8% margin
- EBITDA-₹38.3 Lakh
FY 2025 · -5% margin
- Employee Count47
Associated legal entities of D2L Pharma Research Solutions
D2L Pharma Research Solutions operates through D2l Pharma Research Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| D2l Pharma Research Solutions Private Limited CIN U24232TG2007PTC054728 | Active | 06 Jul 2007 | Hyderabad, Telangana | ₹8.1 Cr | 47 | 4 | View details |
Board of directors of D2l Pharma Research Solutions Private Limited (D2L Pharma Research Solutions)
D2l Pharma Research Solutions Private Limited is the primary company behind D2L Pharma Research Solutions. The board of D2l Pharma Research Solutions Private Limited currently have 4 directors; the longest-serving is Kode Sashi Kiran, appointed in 2007. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kode Sashi Kiran DIN 01562875 | Managing Director | 06 Jul 2007 | 19 yrs 4 mo | D2l Pharma Research Solutions Private Limited |
| Shekhar Gupta DIN 02101816 | Whole-time director | 18 Jan 2008 | 18 yrs 9 mo | D2l Pharma Research Solutions Private Limited |
| Marella Ravikant DIN 02699241 | Whole-time director | 05 Feb 2010 | 16 yrs 9 mo | D2l Pharma Research Solutions Private Limited |
| Sudheesh Kookkal DIN 11354958 | Additional Director | 27 Oct 2025 | 1 yr | D2l Pharma Research Solutions Private Limited |
People of D2L Pharma Research Solutions
2 people are tracked at D2L Pharma Research Solutions (2 in leadership); the tracked headcount is 47.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder, CEO | Leadership |
Complete people profiles for D2L Pharma Research Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of D2L Pharma Research Solutions
Figures of D2l Pharma Research Solutions Private Limited, the primary company behind D2L Pharma Research Solutions, for FY 2025. Revenue was ₹8.09 Cr (+19% year on year). Net loss was -₹68.6 Lakh (-8% margin). EBITDA was -₹38.3 Lakh (-5% margin). Revenue has grown at a compounded annual rate of +2% over three years and +3% over five years.
- ₹8.09 CrRevenue · FY 2025 · +19% YoY
- -₹68.6 LakhNet loss · -8% margin
- -₹38.3 LakhEBITDA · -5% margin
- ₹28.8 LakhPaid-up capital
- 47Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of D2l Pharma Research Solutions Private Limited are on its company page.
Detailed financial statements for D2L Pharma Research Solutions
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about D2L Pharma Research Solutions
D2L Pharma Research Solutions was founded in 2007.
D2L Pharma Research Solutions is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Deepak Harikrishnan is the CEO of D2L Pharma Research Solutions, as recorded in our data. They have also founded this company.
D2L Pharma Research Solutions has 47 employees.
The primary company behind D2L Pharma Research Solutions, D2l Pharma Research Solutions Private Limited, reported revenue of ₹8.09 Cr for FY 2025, up 19% year on year.
D2L Pharma Research Solutions, established in 2007, excels in providing healthcare solutions, producing pharmaceutical products, research consulting, and kol development. Provides consulting services for Key Opinion Leader development in pharmaceuticals. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
D2L Pharma Research Solutions operates through D2l Pharma Research Solutions Private Limited.
The legal entities of D2L Pharma Research Solutions currently have 4 directors, including Marella Ravikant, Shekhar Gupta, Kode Sashi Kiran and others.